Showing all 4 results
Phenazopyridine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Film-Coated Tablet, packed in highly secure, moisture-resistant PVC/PVDC or Alu-PVC blister strips to ensure the stability of the active dye compound.
Active Ingredient Strength Primary Clinical Function Phenazopyridine Hydrochloride USP/Ph.Eur. 100 mg Standard OTC/Initiation dose for mild-to-moderate urinary tract discomfort. Phenazopyridine Hydrochloride USP/Ph.Eur. 200 mg Global Prescription Standard: Maximum adult dose for severe dysuria and post-operative catheter trauma. Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Magnesium Stearate Diluent / Superdisintegrant (Engineered for rapid gastric dissolution and swift renal clearance) Phenazopyridine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant high-density PVC/PVDC or Alu-PVC blister strips to ensure absolute chemical stability and prevent dye leakage.
Active Ingredient Strength Primary Clinical Function Phenazopyridine HCl USP/Ph.Eur. 100 mg OTC Standard: Base therapeutic unit for mild to moderate UTI symptom relief. Phenazopyridine HCl USP/Ph.Eur. 200 mg Prescription Standard: Maximum adult dose for severe, acute dysuria and post-surgical trauma. Excipients Microcrystalline Cellulose / Sodium Starch Glycolate / Povidone / Magnesium Stearate / Heavy Carnauba Wax Coating Diluent / Superdisintegrant / Binder / Lubricant / Premium Film-Coating (Engineered specifically to seal the intense red dye inside the tablet, preventing it from staining the patient’s hands or mouth upon swallowing) *Pack Sizes: 10×10 Blisters (Optimized specifically for high-turnover acute dispensing and short-term 2-day urology protocols).
Silodosin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the active pharmaceutical ingredient.
Active Ingredient Strength Primary Clinical Function Silodosin INN/Ph.Eur. 8 mg Global Clinical Standard: Maximum adult daily dose for the rapid relief of lower urinary tract symptoms (LUTS) associated with BPH. Excipients Mannitol / Pregelatinized Starch / Sodium Stearyl Fumarate / Hypromellose / Titanium Dioxide Diluent / Binder / Lubricant / Film-Coating (Engineered for highly synchronized gastric dissolution and optimal bioavailability) *Pack Sizes: 10×10 Alu-Alu Blisters (Optimized specifically for high-compliance 30-day urology dispensing regimens).
Solifenacin Succinate Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu or High-Density Alu-PVC blister strips to ensure the absolute stability of the low-dose API.
Active Ingredient Strength Primary Clinical Function Solifenacin Succinate USP/Ph.Eur. 5 mg Global Standard: Starting and standard maintenance dose for Overactive Bladder; required maximum dose for patients with hepatic/renal impairment. Solifenacin Succinate USP/Ph.Eur. 10 mg High-Dose Therapy: Maximum adult dose for severe, refractory urinary urgency and frequency. Excipients Lactose Monohydrate / Maize Starch / Hypromellose / Magnesium Stearate / Macrogol Diluent / Binder / Premium Film-Coating (Engineered for immediate gastric dissolution and light protection)
